


Ask a doctor about a prescription for ETORICOXIB TEVA 120 mg FILM-COATED TABLETS
Leaflet: information for the user
Etoricoxib Teva 30 mg film-coated tablets EFG
Etoricoxib Teva 60 mg film-coated tablets EFG
Etoricoxib Teva 90 mg film-coated tablets EFG
Etoricoxib Teva 120 mg film-coated tablets EFG
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
What is Etoricoxib Teva?
What is Etoricoxib Teva used for?
What is osteoarthritis?
Osteoarthritis is a disease of the joints. It causes the gradual breakdown of cartilage that cushions the ends of bones. This causes swelling (inflammation), pain, sensitivity, stiffness, and disability.
What is rheumatoid arthritis?
Rheumatoid arthritis is a long-term inflammatory disease of the joints. It causes pain, stiffness, swelling, and progressive loss of mobility in the affected joints. It also causes inflammation in other areas of the body.
What is gout?
Gout is a disease of sudden and recurrent attacks of very painful and reddened joint inflammation. It is caused by deposits of mineral crystals in the joint.
What is ankylosing spondylitis?
Ankylosing spondylitis is an inflammatory disease of the spine and long joints.
Do not take Etoricoxib Teva:
Etoricoxib may slightly increase your risk of heart attack and stroke, and therefore should not be used in patients who have already had heart problems or a stroke.
If you think you may be in any of these situations, do not take the tablets until you have consulted your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Etoricoxib Teva if:
If you are unsure whether any of the above situations apply to you, talk to your doctor before taking Etoricoxib Teva to check if this medication is suitable for you.
Etoricoxib Teva works just as well in adult and young patients. If you are over 65 years old, your doctor will want to keep a close eye on you. No dose adjustment is necessary in patients over 65 years old.
Children and adolescents
Do not give this medication to children and adolescents under 16 years of age.
Taking Etoricoxib Teva with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication, including those purchased without a prescription.
In particular, if you are taking any of the following medications, your doctor may want to monitor you to check that your medications are working properly once you start taking Etoricoxib Teva:
Pregnancy, breastfeeding, and fertility
Pregnancy
Etoricoxib Teva should not be taken during pregnancy. Do not take the tablets if you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Consult your doctor if you have any doubts or need more information.
Breastfeeding
It is not known if etoricoxib is excreted in human milk. If you are breastfeeding or plan to breastfeed, consult your doctor before taking Etoricoxib Teva. If you are using Etoricoxib Teva, do not breastfeed.
Fertility
Etoricoxib Teva is not recommended for use in women who are trying to become pregnant.
Driving and using machines
In some patients taking Etoricoxib Teva, dizziness and drowsiness have been reported.
Do not drive if you experience dizziness or drowsiness.
Do not use tools or machines if you experience dizziness or drowsiness.
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
There are different doses available for this medication, and depending on your disease, your doctor will prescribe the tablet with the dose that is suitable for you.
The recommended dose is:
Osteoarthritis
The recommended dose is 30 mg once a day, increasing to a maximum of 60 mg once a day if necessary.
Rheumatoid arthritis
The recommended dose is 60 mg once a day, increasing to a maximum of 90 mg once a day if necessary.
Ankylosing spondylitis
The recommended dose is 60 mg once a day, increasing to a maximum of 90 mg once a day if necessary.
Acute pain situations
Etoricoxib should only be used during the period of acute pain.
Gout
The recommended dose is 120 mg once a day, which should only be used during the period of acute pain, limited to a maximum of 8 days of treatment.
Postoperative dental pain
The recommended dose is 90 mg once a day, limited to a maximum of 3 days of treatment.
Patients with liver problems
Do not take more than the recommended dose for your disease. Your doctor will want to discuss your treatment from time to time. It is important that you use the lowest dose that controls your pain and do not take Etoricoxib Teva for longer than necessary. This is because the risk of heart attacks and strokes could increase after prolonged treatment, especially with high doses.
Use in children and adolescents
Children or adolescents under 16 years of age should not take Etoricoxib Teva.
Elderly patients
No dose adjustment is necessary in elderly patients. As with other medications, caution should be exercised in elderly patients.
Method of administration
Etoricoxib Teva is administered orally.
Take the tablets once a day. Etoricoxib Teva can be taken with or without food.
If you take more Etoricoxib Teva than you should
Never take more tablets than your doctor recommends. If you take too many Etoricoxib Teva tablets, seek medical attention immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Etoricoxib Teva
It is important that you take Etoricoxib Teva as your doctor has indicated. If you forget a dose, simply resume your usual regimen the next day.
Do not take a double dose to make up for forgotten doses.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
If you develop any of these signs, stop taking Etoricoxib Teva and talk to your doctor immediately (see section 2 What you need to know before taking Etoricoxib Teva):
The following side effects may occur during treatment with Etoricoxib Teva:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 patients)
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and blister after EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from light.
Do not use this medication if you notice visible signs of deterioration.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Etoricoxib Teva Composition
The active ingredient is etoricoxib.
Each film-coated tablet contains 30 mg of etoricoxib.
Each film-coated tablet contains 60 mg of etoricoxib.
Each film-coated tablet contains 90 mg of etoricoxib.
Each film-coated tablet contains 120 mg of etoricoxib.
Core: hydrogenated calcium phosphate (anhydrous), crospovidone (type A), microcrystalline cellulose, povidone K25, magnesium stearate.
Tablet coating: hypromellose, hydroxypropylcellulose, talc, medium-chain triglycerides, titanium dioxide (E171), microcrystalline cellulose (30 mg), red iron oxide (30 mg) (E172), aluminum lake indigo carmine (30, 60, and 120 mg) (E132), aluminum lake brilliant blue (60 and 120 mg) (E133), yellow iron oxide (60 and 120 mg) (E172), black iron oxide (60 and 120 mg) (E172).
Product Appearance and Package Contents
30 mg film-coated tablet, blue, round, biconvex, marked with "30" on one side and smooth on the other.
60 mg film-coated tablet, dark green, round, biconvex, marked with "60" on one side and smooth on the other.
90 mg film-coated tablet, white, round, biconvex, marked with "90" on one side and smooth on the other.
120 mg film-coated tablet, light green, round, biconvex, marked with "120" on one side and smooth on the other.
Package sizes:
30 mg
OPA/Alu/PVC - Aluminum blister packs containing 7, 14, 28, 28x1, 30, 98 film-coated tablets.
60 mg
OPA/Alu/PVC - Aluminum blister packs containing 7, 14, 20, 28, 28x1, 30, 50, 98, 100 film-coated tablets.
90 mg
OPA/Alu/PVC - Aluminum blister packs containing 5, 7, 7x1, 14, 20, 28, 28x1, 30, 50, 98, 100 film-coated tablets.
120 mg
OPA/Alu/PVC - Aluminum blister packs containing 5, 7, 7x1, 14, 16, 20, 28, 28x1, 30 film-coated tablets.
Not all package sizes may be marketed.
Marketing Authorization Holder
Teva Pharma, S.L.U.
C/ Anabel Segura, 11. Edificio Albatros B, 1ª planta.
28108 Alcobendas, Madrid
Spain
Manufacturer
Teva Gyógyszergyár Zrt.
Debrecen, Pallagi út 13,
H-4042
Hungary
or
Teva Nederland BV
Swensweg 5, Haarlem
2031 GA
Netherlands
or
Teva Czech Industries s.r.o.
Ostravska 29, c.p. 305, Opava-Komarov
74770
Czech Republic
or
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80,
Krakow, 31-546
Poland
or
Teva Pharma, S.L.U.
C/C, n. 4, Polígono Industrial Malpica,
Zaragoza, 50016
Spain
or
Merckle GmbH
Ludwig-Merckle-Straße 3,
Blaubeuren, 89143
Germany
or
PLIVA Hrvatska d.o.o. (PLIVA Croatia Ltd.)
Prilaz baruna Filipovica 25, Zagreb
10000
Croatia
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Bulgaria: ??????????? ???? 30 mg, 60 mg, 90 mg, 120 mg ????????? ????????
Croatia: Coxeta 30 mg, 60 mg, 90 mg & 120 mg film-coated tablets
Estonia: Etoricoxib Teva
Germany: Etoricox-AbZ 30 mg, 60 mg, 90 mg & 120 mg film-coated tablets
Ireland: Etoricoxib Teva 30 mg, 60 mg, 90 mg & 120 mg film-coated tablets
Italy: ETORICOXIB TEVA
Latvia: Etoricoxib Teva 60mg, 90 mg, 120 mg film-coated tablets
Lithuania: Etoricoxib Teva 30 mg, 60mg, 90 mg, 120 mg film-coated tablets
Malta: Etoricoxib Teva 30 mg, 60 mg, 90 mg & 120 mg film-coated tablets
Poland: Etoricoxib Teva
Portugal: Etoricoxib Teva
Romania: ETORICOXIB TEVA 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets
Slovenia: Coxeta 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets
Spain: Etoricoxib Teva 30 mg, 60 mg, 90 mg y 120 mg film-coated tablets EFG
Sweden: Etoricoxib Teva 30 / 60 / 90 / 120 mg film-coated tablets
Netherlands: Etoricoxib Teva 30 mg, 60 mg, 90 mg, 120 mg, film-coated tablets
United Kingdom: Etoricoxib 30mg, 60mg, 90mg & 120mg film-coated tablets
Date of the last revision of thisleaflet:September 2016
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The average price of ETORICOXIB TEVA 120 mg FILM-COATED TABLETS in December, 2025 is around 5.37 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ETORICOXIB TEVA 120 mg FILM-COATED TABLETS – subject to medical assessment and local rules.